TTBB CAS 124750-51-2 Kemurnian > 96,0% (HPLC) Irbesartan Intermediate Factory
Ruifu Chemical Supply Irbesartan Intermediates:
Irbesartan CAS 138402-11-6
Cyano-Irbesartan CAS 138401-24-8
Trityl Irbesartan CAS 138402-10-5
TTBB CAS 124750-51-2
Irbesartan Side Chain Hydrochloride CAS 151257-01-1
Jeneng Kimia | 5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazol |
sinonim | TTBB;BBTT;5-[4'-Bromomethyl-(1,1'-Biphenyl)-2-yl]-1-Triphenylmethyltetrazol;N-(Triphenylmethyl)-5-(4'-Bromomethylbiphenyl-2-yl-)tetrazol;Olmesartan Impurity 12;Losartan Bromo N1-Trityl Impurity |
Nomer CAS | 124750-51-2 |
Nomer CAT | RF-PI1878 |
Status Simpenan | Ing Simpenan, Kapasitas Produksi 150MT / Taun |
Formula Molekul | C33H25BrN4 |
Bobot Molekul | 557.48 |
Titik Lebur | 152.0~155.0 ℃ |
Kapadhetan | 1,28±0,10 g/cm3 |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Bubuk putih nganti meh putih |
Kemurnian / Metode Analisis | > 96,0% (HPLC) |
Mundhut ing Pangatusan | <0,50% |
Najis A | <2,00% (HPLC) 5-(4-Metil-1,1-Bifenil-2-yl)-1-Trifenilmetil-1H-Tetrazol |
Najis B | <2,00% 5-(4'.4'-Dibromomethyl-1,1-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazol |
Spektrum Infra Merah | Conforms kanggo Struktur |
Test Standar | Standar Perusahaan |
Panggunaan | Penengah saka Irbesartan (CAS: 138402-11-6);Olmesartan Medoxomil Impurity |
Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan
5-(4'-Bromomethyl-1,1'-Biphenyl-2-yl)-1-Triphenylmethyl-1H-Tetrazol (TTBB) (CAS: 124750-51-2) minangka perantara saka Irbesartan (CAS: 138402-11 -6).Irbesartan digunakake kanggo perawatan hipertensi, uga nephropathy diabetes kanthi tingkat bun serum lan proteinuria (> 300 mg / dina) ing pasien diabetes jinis 2 lan hipertensi.Irbesartan uga digunakake minangka agen baris kapindho ing perawatan conges.Irbesartan minangka antagonis reseptor angiotensin II sing digunakake utamane kanggo perawatan hipertensi.Iki dikembangake dening Sanofi Research (saiki dadi bagean saka Sanofi-Aventis).Iki dipasarake bebarengan dening Sanofi-Aventis lan Bristol-Myers Squibb kanthi jeneng dagang Aprovel, Karvea, lan Avapro.